
BridgeBio sales of new heart drug outstrip expectations
Dive Brief: Sales of BridgeBio’s new heart medicine Attruby blew past analyst expectations in the first quarter, as the company built by “science nerds” took on market behemoth Pfizer. Net product revenue reached $36.7 million in the period, surpassing the …